Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2316674
Max Phase: Preclinical
Molecular Formula: C38H56N4O11
Molecular Weight: 744.88
Molecule Type: Small molecule
Associated Items:
ID: ALA2316674
Max Phase: Preclinical
Molecular Formula: C38H56N4O11
Molecular Weight: 744.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\OCC#Cc2cncnc2)[C@H](C)[C@H]2OC(=O)O[C@@]21C
Standard InChI: InChI=1S/C38H56N4O11/c1-12-28-38(8)33(52-36(46)53-38)23(4)29(41-48-15-13-14-26-18-39-20-40-19-26)21(2)17-37(7,47-11)32(24(5)30(43)25(6)34(45)50-28)51-35-31(44)27(42(9)10)16-22(3)49-35/h18-25,27-28,31-33,35,44H,12,15-17H2,1-11H3/b41-29+/t21-,22-,23+,24+,25-,27+,28-,31-,32-,33-,35+,37-,38-/m1/s1
Standard InChI Key: MVADRHURRVRRCU-QKIZNIJLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 744.88 | Molecular Weight (Monoisotopic): 744.3946 | AlogP: 3.55 | #Rotatable Bonds: 7 |
Polar Surface Area: 177.43 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.93 | CX Basic pKa: 8.27 | CX LogP: 4.81 | CX LogD: 4.20 |
Aromatic Rings: 1 | Heavy Atoms: 53 | QED Weighted: 0.14 | Np Likeness Score: 1.04 |
1. Liang JH, An K, Lv W, Cushman M, Wang H, Xu YC.. (2013) Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides., 59 [PMID:23202851] [10.1016/j.ejmech.2012.10.054] |
Source(1):